Health Equity Studio

Community Partnerships: An Essential Component to Advance Health Equity

Community partnerships can help to identify and alleviate some of the disparities caused by social determinants of health. Dr. Titilope Fasipe shares her story with sickle cell disease as a patient and physician discussing best practices to partner with community groups.

How to Support LGBTQIA Patients, Trainees, and Colleagues: A Whole Person Perspective

Dr. Susanna Curtis explains the importance of language when advocating for your LGBTQIA+ patients, trainees, and colleagues. Using real life experiences, they share efforts on how to move the needle at your institution. This session highlights how to advocate for patients in clinical settings.

Legally Intentional: Microlearning Session on Systemic Racism

Dr. Curtis Henry addresses equity in healthcare in a post-affirmative action environment. Dr. Henry uses real life examples to illustrate how you can help empower underrepresented trainees and faculty in hematology. This session provides you with key strategies to create change in your institution.

Outcome Disparities in Hematologic Diseases: The Importance of Social Determinants of Health

Racial and ethnic disparities in blood diseases raise questions about the influence of social determinants of health. Dr. Justine Kahn talks about how addressing disparities requires incorporating assessments of social determinants into our clinical practice, research programs, and into medical education.

Systemic Racism in Hematology

Dr. Maureen Achebe uses a multiple myeloma case to demonstrate how systemic racism negatively impacts hematology patient outcomes. Practical strategies are discussed to reduce implicit bias and the effect racism has on patients.

Using Research to Advance Equity in the LGBTQIA+ Space

Dr. Warren Fingrut illustrates the history of mistrust for LGBTQIA+ peoples with the healthcare system. He provides an overview of existing research while highlighting the gaps that remain to address barriers to inclusion impacting LGBTQIA+ patients and donors. Dr. Fingrut emphasizes the importance of identifying this population in practice to advance equity for these patients through research.